Literature DB >> 23643740

Medicines combinations options and regulatory hurdles.

Ole J Bjerrum1, Yvonne Gautam, Esben J Bjerrum, Merete Schmiegelow, Harrie C M Boonen.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23643740     DOI： 10.1016/j.ejps.2013.04.028

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN： 0928-0987            Impact factor:   4.384


× No keyword cloud information.
  2 in total

Review 1.  Treatment of Acute Cough Due to the Common Cold: Multi-component, Multi-symptom Therapy is Preferable to Single-Component, Single-Symptom Therapy--A Pro/Con Debate.

Authors:  Ronald Eccles; Ronald B Turner; Peter V Dicpinigaitis
Journal:  Lung       Date:  2015-09-29       Impact factor: 2.584

2.  New Perspectives for Fixed Dose Combinations of Poorly Water-Soluble Compounds: a Case Study with Ezetimibe and Lovastatin.

Authors:  Manoela K Riekes; Axel Engelen; Bernard Appeltans; Patrick Rombaut; Hellen K Stulzer; Guy Van den Mooter
Journal:  Pharm Res       Date:  2016-02-08       Impact factor: 4.200
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.